L4 Herpes MLS Diploma - Tagged
General Background
Herpes viruses are significant human pathogens characterized as large enveloped DNA viruses, acquiring their envelope from the nuclear membrane.
They are known for their ability to produce latent (asymptomatic lifelong) and recurrent (reactivated) infections.
These viruses are widespread, affecting a majority of the human population.
Herpes viruses can induce various effects in host cells:
Lytic infections: kill the host cell
Persistent infections: continuously produce the virus, usually asymptomatic
Latent infections: minimal viral activity
Immortalized infections: notably seen in Epstein-Barr virus (EBV)
Their genomes encode several proteins and enzymes crucial for viral replication and immune evasion, making them viable targets for antiviral therapy.
Classification of Human Herpes Viruses
Human herpes viruses are classified based on their viral characteristics, including:
Genome structure
Tissue tropism
Cytopathology effects
Site of latent infection
Structure of Herpes Viruses
Composed of:
Envelope proteins (gB-gN)
Lipid envelope
Tegument or Matrix
DNA Nucleocapsid
Structure is large, enveloped, and has an icosahedral capsid.
Human Herpesvirus Genome
The herpes virus genome consists of double-stranded linear DNA (~150 Kb).
There is little DNA homology between various herpes viruses, except between HSV-1 and HSV-2, which are very similar.
Life Cycle of Herpes Viruses
The life cycle involves several steps:
Attachment and Fusion: Viral envelope merges with the host plasma membrane allowing capsid entry.
Uncoating: Delivery of viral DNA into the nucleus.
Viral Gene Expression: Transcription and translation of viral proteins.
DNA Replication: Producing more viral DNA.
Viral Assembly: Formation of new virus particles.
Budding and Release: The virus acquires its envelope and is released, either through lysis or exocytosis.
Latency occurs with minimal viral production, particularly in neurons.
Herpes Simplex Viruses (HSV)
There are two types: HSV-1 and HSV-2, both prevalent in the population (approximately 65% have HSV-1 and 15% have HSV-2 in the US).
HSV-1 typically affects areas above the waist (e.g., oral), while HSV-2 is associated with below-the-waist infections (e.g., genital).
Both types are capable of causing lytic infections in epithelial cells and establishing latent infections in neurons.
Diseases Caused by HSV-1 and HSV-2
Herpes Labialis: Commonly caused by HSV-1 (often referred to as cold sores).
Genital Herpes: More frequently caused by HSV-2 but can also be due to HSV-1.
Herpes Encephalitis: Typically caused by HSV-1, leading to severe morbidity and mortality.
Neonatal HSV: Passed from mother during delivery, potentially leading to severe outcomes due to the immature immune system.
Latency of HSV
HSV-1 establishes latency in trigeminal ganglia, while HSV-2 affects sacral ganglia.
Reactivations may occur asymptomatically, with viral shedding.
Triggers of HSV Recurrences
Common triggers for reactivation include:
Ultraviolet light
Fever
Stress (emotional and physical)
Menstruation
Immunosuppression
Laboratory Diagnosis of HSV Infections
Methods include:
Direct microscopic examination (Tzanck smear)
Cell culture
PCR for HSV DNA detection
HSV Antivirals
Antiviral treatments include:
Acyclovir, Valacyclovir, Famciclovir: Guanosine analogs that inhibit viral DNA polymerase.
Foscarnet: An inhibitor of viral DNA/RNA polymerase used for acyclovir-resistant strains.
Cidofovir: Similar to foscarnet, effective for resistant HSV.
These medications can reduce severity of infections but do not cure latent infections.
Varicella Zoster Virus (VZV)
Primary disease manifests as chicken pox; reactivation causes shingles.
Infection occurs via respiratory droplet, with a characteristic rash developing after a few days.
Post-herpetic neuralgia is a common complication following shingles.
Epstein-Barr Virus (EBV)
Known for inducing B cell proliferation and latency in memory B cells.
Symptoms can range from subclinical to infectious mononucleosis (kissing disease).
Diagnosis often involves detecting atypical lymphocytes and specific viral antibodies.
Cytomegalovirus (CMV)
Recognized for its larger genome and immune evasion capabilities, often affecting immunocompromised patients.
CMV can be transmitted through saliva, genital fluids, and vertically from mother to child.
Symptoms vary significantly based on the individual's immune status, with serious implications for neonates.